Skip to content

    BIODESIX (BDSX) stock price & financials

    View BDSX earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+185.4% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $18.15M
    $20.43M
    $17.96M
    $20.02M
    $21.77M
    +19.9%
    $28.75M
    +40.8%
    $25.55M
    +42.3%
    $26.86M
    +34.2%
    Strengthening
    Operating Profit
    -$8.59M
    -$6.65M
    -$9.14M
    -$9.72M
    -$7.05M
    +17.9%
    -$1.97M
    +70.4%
    -$6.20M
    +32.1%
    -$5.39M
    +44.6%
    Strengthening
    Net Profit
    -$10.26M
    -$8.25M
    -$11.10M
    -$11.47M
    -$8.72M
    +15.0%
    -$3.98M
    +51.8%
    -$7.79M
    +29.8%
    -$7.27M
    +36.6%
    Strengthening
    EPS
    $-1.40
    $-1.52
    $-1.56
    $-1.16
    +17.1%
    $-0.81
    +46.7%
    $-0.71
    +54.5%
    Strengthening
    Other Income
    -$1.67M
    -$1.60M
    -$1.97M
    -$1.75M
    -$1.67M
    +0.1%
    -$2.01M
    -25.7%
    -$1.59M
    +19.0%
    -$1.89M
    -7.8%
    Weakening
    Interest
    $2.04M
    $1.75M
    $1.69M
    $1.90M
    $2.07M
    +1.6%
    $2.06M
    +17.5%
    $1.98M
    +17.3%
    $1.98M
    +4.4%
    Strengthening
    Depreciation
    Profit before Tax
    MarginsOPM
    -47.3%
    -32.5%
    -50.9%
    -48.5%
    -32.4%
    +31.6%
    -6.8%
    +79.0%
    -24.3%
    +52.3%
    -20.1%
    +58.7%
    Strengthening
    Tax
    ReturnsROIC
    2.0%
    1.6%
    2.2%
    2.2%
    1.7%
    -15.0%
    0.8%
    -51.8%
    1.5%
    -29.8%
    1.4%
    -36.6%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$5.29M$62.13M$32.71M$43.09M$26.28M$26.25M$18.99M$30.00M
    Short-Term Investments
    Total Current Assets$12.70M$86.14M$43.61M$53.33M$39.68M$39.48M$32.52M$43.56M
    Net PP&E$2.12M$3.18M$5.68M$8.82M$29.61M$29.59M$27.81M$27.34M
    Goodwill$15.03M$15.03M$15.03M$15.03M$15.03M$15.03M$15.03M$15.03M
    Intangibles$15.09M$13.26M$11.62M$9.80M$7.91M$5.87M$3.88M$2.98M
    Total Assets$45.03M$121.07M$76.10M$92.91M$99.10M$97.24M$87.48M$95.33M
    LiabilitiesTotal Current Liabilities$22.60M$32.13M$28.96M$22.84M$33.42M$14.32M$17.44M$15.29M
    Short-Term Debt
    Long-Term Debt$28.08M$10.07M$30.13M$40.08M$40.03M$50.01M$50.00M
    Long-Term Leases$5.25M$25.16M$24.83M$24.04M$23.37M
    Total Liabilities$76.21M$79.90M$56.37M$72.30M$94.52M$76.37M$89.94M$86.18M
    EquityCommon Stock & APIC$1.0K$27.0K$31.0K$78.0K$96.0K$7.0K$8.0K$11.0K
    Retained Earnings-$227.46M-$258.81M-$301.97M-$367.42M-$419.57M-$462.50M-$497.76M-$512.83M
    Total Equity-$225.14M$41.17M$19.73M$20.61M$4.58M$20.88M-$2.46M$9.14M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$21.73M-$21.37M-$28.22M-$44.97M-$22.87M-$48.65M-$23.27M-$19.83M
    Cash from Investing-$1.87M-$2.93M-$2.55M-$3.53M-$23.06M-$3.44M-$403.0K-$569.0K
    Cash from Financing$22.97M$81.13M$1.26M$58.88M$29.13M$52.05M$16.42M$29.67M
    SummaryCapital Expenditure-$1.31M-$1.95M-$2.24M-$3.30M-$22.92M-$3.23M-$259.0K-$412.0K
    Free Cash Flow-$23.04M-$23.31M-$30.46M-$48.27M-$45.79M-$51.88M-$23.53M-$20.24M
    FCF Margin-93.8%-51.2%-55.9%-126.3%-93.3%-72.7%-26.6%-19.7%

    Ratios